You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for NIACIN ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NIACIN ER

Average Pharmacy Cost for NIACIN ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NIACIN ER 1,000 MG TABLET 00093-7394-98 0.21941 EACH 2024-12-18
NIACIN ER 1,000 MG TABLET 47335-0613-81 0.21941 EACH 2024-12-18
NIACIN ER 1,000 MG TABLET 59651-0020-18 0.21941 EACH 2024-12-18
NIACIN ER 1,000 MG TABLET 33342-0189-10 0.21941 EACH 2024-12-18
NIACIN ER 750 MG TABLET 68180-0222-01 0.34045 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Niacin ER

Introduction to Niacin ER

Niacin, or nicotinic acid, is a vital nutrient and a member of the miscellaneous antihyperlipidemic agents drug class. It is commonly used for managing high cholesterol, dietary supplementation, and other health conditions. Extended-release (ER) formulations of niacin have been widely prescribed due to their efficacy in improving lipid profiles.

Historical Market Trends

Historically, the use of niacin, particularly in its extended-release form, has seen significant growth. Between 2002 and 2009, niacin prescriptions in the United States increased by 191.2%, reaching approximately 696,000 prescriptions per month by the end of 2009. This surge was largely driven by the introduction of proprietary, prescription extended-release niacin formulations like Niaspan, which accounted for 81.6% of all niacin prescriptions in the U.S. in 2009[1][4].

Market Size and Growth

The global market for niacin and niacinamide is substantial and growing. In 2022, the market size was estimated at $9.71 billion, and it is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.5%, reaching $13.22 billion by 2029. This growth is driven by increasing demand in various applications, including pharmaceuticals, cosmeceuticals, human nutrition, and animal nutrition[3].

Regional Market Analysis

  • North America: The U.S. has been a significant market for niacin, with high prescription rates. However, the introduction of generic versions and changes in consumer sentiments have affected market dynamics[1][4].
  • Europe: The European market has faced challenges such as supply chain disruptions and competition from cheap imports, leading to price stagnation[5].
  • Asia: In Asia, niacin prices have remained stagnant due to weak demand from both domestic and international sectors, influenced by factors like raw material costs and trade tensions[5].
  • Other Regions: Markets in the Middle East, Africa, and South America also play a role, though they are generally smaller compared to the major regions.

Pricing and Cost Analysis

The cost of niacin ER varies based on dosage and quantity. Here are some current price ranges:

  • 500 mg Oral Tablet, Extended Release: Approximately $36.64 for a supply of 30 tablets[2].
  • 750 mg Oral Tablet, Extended Release: Around $136.01 for 90 tablets[2].
  • 1000 mg Oral Tablet, Extended Release: About $211.82 for 90 tablets[2].

These prices are subject to fluctuations based on factors such as pharmacy location, stock shortages, and insurance coverage.

Price Trends and Projections

Recent Trends

In the second half of 2023, niacin prices faced several challenges globally:

  • Asia: Prices remained stagnant due to weak demand and trade tensions[5].
  • Europe: Initial price increases due to supply chain disruptions were short-lived, and prices eventually stagnated due to steady demand and competition from cheap imports[5].
  • North America: Prices were affected by rising raw material costs, consumer confidence fluctuations, and disruptions in trade routes, leading to reduced advertised prices[5].

Future Projections

The price trend of niacin is expected to continue its downward trajectory in the near future due to several factors:

  • Declining Demand: Consistently declining demand from downstream sectors such as pharmaceuticals and nutraceuticals is expected to keep prices low[5].
  • Raw Material Costs: The cost of raw materials, such as tryptophan, will continue to influence niacin prices. Weak support from the raw materials sector can lead to price stagnation or decline[5].
  • Global Trading Activities: Trade tensions, currency fluctuations, and supply chain disruptions will likely impact niacin prices negatively[5].

Key Applications and Market Segments

Pharmaceuticals

Niacin ER is widely used in the pharmaceutical sector for managing cardiovascular diseases by improving lipid profiles. The dominance of this segment is due to its efficacy in raising HDL-C (good cholesterol) levels and reducing triglycerides and LDL-C (bad cholesterol)[1][4].

Animal Nutrition

The animal nutrition segment is another significant market for niacin, particularly in reducing ketosis in dairy cattle and increasing milk production. This segment has been a major driver of the niacin market due to its beneficial effects on animal health and productivity[3].

Cosmeceuticals and Human Nutrition

Niacin and niacinamide are also used in cosmeceuticals for their skin benefits and in human nutrition as dietary supplements. These segments, while smaller, contribute to the overall growth of the niacin market[3].

Competitive Analysis

The niacin market is competitive with several key players:

  • Brother Enterprises Holding Co., Ltd.
  • Zhejiang NHU Company Ltd.
  • Fagron NV
  • Vertellus Specialties Inc.
  • Jubilant Life Sciences Limited
  • Evonik Industries AG

These companies compete based on factors such as product quality, price, and regional presence[3].

Regulatory and Market Dynamics

The use of niacin ER is influenced by regulatory approvals and market dynamics. For instance, the introduction of generic versions of extended-release niacin in 2013 significantly impacted the market, leading to increased competition and changes in pricing strategies[1][4].

Consumer and Prescriber Behavior

Consumer and prescriber behavior play crucial roles in the niacin market. Direct-to-consumer advertising, for example, has been a significant factor in increasing the use of niacin ER, particularly in the United States[4].

Key Takeaways

  • Historical Growth: Niacin ER prescriptions have seen significant growth, driven by proprietary formulations and direct-to-consumer advertising.
  • Market Size and Growth: The global niacin and niacinamide market is projected to grow at a CAGR of 4.5%, reaching $13.22 billion by 2029.
  • Pricing Trends: Current prices vary by dosage, and future trends are expected to be influenced by declining demand, raw material costs, and global trading activities.
  • Key Applications: Pharmaceuticals, animal nutrition, cosmeceuticals, and human nutrition are the main segments driving the market.
  • Competitive Landscape: The market is competitive with several key players competing on product quality, price, and regional presence.

FAQs

What is the current market size of the niacin and niacinamide market?

The current market size of the niacin and niacinamide market was estimated at $9.71 billion in 2022[3].

What is the projected growth rate of the niacin and niacinamide market?

The niacin and niacinamide market is anticipated to grow at a CAGR of 4.5% from 2023 to 2029[3].

Which segment dominates the niacin and niacinamide market?

The animal nutrition segment currently dominates the niacin and niacinamide market due to its benefits in reducing ketosis in dairy cattle and increasing milk production[3].

What are the key factors influencing niacin prices?

Niacin prices are influenced by factors such as raw material costs, demand from downstream sectors, global trading activities, and supply chain disruptions[5].

Who are the major players in the niacin and niacinamide market?

Major players include Brother Enterprises Holding Co., Ltd., Zhejiang NHU Company Ltd., Fagron NV, Vertellus Specialties Inc., Jubilant Life Sciences Limited, and Evonik Industries AG[3].

How has the introduction of generic versions affected the niacin market?

The introduction of generic versions of extended-release niacin has increased competition and impacted pricing strategies, leading to changes in market dynamics[1][4].

Sources

  1. Assessment of the Role of Niacin in Managing Cardiovascular ... - JAMA Network
  2. Niacin Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Niacin and Niacinamide Market: Global Analysis and Forecast (2023 ... - Maximize Market Research
  4. Use of Niacin in the United States and Canada - JAMA Network
  5. Niacin Price Trend and Forecast - Procurement Resource

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.